Coronavirus: Russia begins vaccine programme as Sputnik doses given out in Moscow
Trials show Sputnik V is 92 per cent effective, but final clinical trials yet to be completed
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Russia has started its coronavirus vaccination programme, with jabs being given to those most at risk of exposure to the disease at 70 clinics across Moscow.
The Russian-made Sputnik V Covid-19 shot is first being offered to doctors and other medical workers, teachers and social workers.
“You are working at an educational institution and have top-priority for the Covid-19 vaccine, free of charge,” read a text message received by one Muscovite, an elementary school teacher, early on Saturday and seen by Reuters.
Sergei Sobyanin, the mayor of Moscow, said 5,000 doctors, teachers and social workers signed up for the vaccine in five hours.
The age for those receiving shots is capped at 60, and people with certain underlying health conditions, pregnant women and those who have had a respiratory illness for the past two weeks are barred from vaccination.
Russia has developed two Covid-19 vaccines, Sputnik V which is backed by the Russian Direct Investment Fund and another developed by Siberia’s Vector Institute.
The vaccines have received regulatory approval in Russia, but final clinical trials to test the safety and efficacy of both are yet to be completed.
Scientists have raised concerns about the speed at which Russia has worked.
Interim trials showed Sputnik V is 92 per cent effective at protecting people from Covid-19.
The vaccine is administered in two injections, with the second dose is expected to be given 21 days after the first.
Moscow, the epicentre of Russia’s coronavirus outbreak, closed down all public places including parks and cafes, except for deliveries, in late March and police patrolled the streets looking for those violating the rules.
The restrictions were eased from mid-June, but certain measures, such as remote learning for some secondary school children and a 30 per cent limit on the number of workers allowed in offices, were reintroduced in October.
Russia reported a record high 28,782 new coronavirus infections on Saturday, pushing the national total to 2,431,731 since the pandemic began, the fourth-highest in the world.
Of the new cases, 7,993 were in Moscow. This was up from 6,868 the day before and well above the daily tallies of around 700 seen in early September.
Authorities confirmed 508 coronavirus-related deaths in the past 24 hours, pushing the national death toll to 42,684.
Additional reporting by agencies
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments